BioSenic progresses cGvHD system and submits patent to EPO by John Pinching | May 4, 2023 | News | 0 Patent will allow the development of an industrial biomarker analysis kit which could be available worldwide Read More
AbbVie/Janssen’s Imbruvica filed for graft-versus-host-disease by Selina McKee | Apr 5, 2017 | News | 0 US regulators have agreed to review AbbVie and Janssen’s Imbruvica for previously treated chronic graft-versus-host-disease (cGVHD), a severe, potentially life-threatening consequence of stem cell or bone marrow transplant. Read More